In this issue of Endocrinology and Metabolism Clinics of North America, guest editors Drs. Sherouk Fouda and Joseph M. Pappachan bring their considerable expertise to the topic of Metabolic Associated Fatty Liver Disease. Top experts address the various ways metabolic associated fatty liver disease is related to other conditions such as diabetes, sarcopenia, PCOS, and more, as well as the management of MAFLD and cardiovascular implications.
Contains 12 practice-oriented topics including obstructive sleep apnea and MAFLD; the interlink between MAFLD and polycystic ovary syndrome; pregnancy and MAFLD; MAFLD and gut microbiota; and more.
Provides in-depth clinical reviews of metabolic associated fatty liver disease, offering actionable insights for clinical practice.
Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. xi 7. Foreword - p. xiii 8. Preface - p. xv 9. Pathobiology of Metabolic-Associated Fatty Liver Disease - p. 405 10. Metabolic-Associated Fatty Liver Disease in Childhood and Adolescence - p. 417 11. Lean Metabolic-Associated Fatty Liver Disease - p. 431 12. Lipid Disorders and Metabolic-Associated Fatty Liver Disease - p. 445 13. Cardiovascular Implications of Metabolic Dysfunction-Associated Fatty Liver Disease - p. 459 14. Metabolic-Associated Fatty Liver Disease and Diabetes: A Double Whammy - p. 469 15. Metabolic-Associated Fatty Liver Disease and the Gut Microbiota - p. 485 16. Metabolic-Associated Fatty Liver Disease and Sarcopenia - p. 497 17. A Bidirectional Association Between Obstructive Sleep Apnea and Metabolic-Associated Fatty Liver Disease - p. 509 18. Pregnancy and Metabolic-Associated Fatty Liver Disease - p. 521 19. The Interlink Between Metabolic-Associated Fatty Liver Disease and Polycystic Ovary Syndrome - p. 533 20. Management of Metabolic-Associated Fatty Liver Disease - p. 547
In this issue of Endocrinology and Metabolism Clinics of North America, guest editors Drs. Sherouk Fouda and Joseph M. Pappachan bring their considerable expertise to the topic of Metabolic Associated Fatty Liver Disease. Top experts address the various ways metabolic associated fatty liver disease is related to other conditions such as diabetes, sarcopenia, PCOS, and more, as well as the management of MAFLD and cardiovascular implications.
Contains 12 practice-oriented topics including obstructive sleep apnea and MAFLD; the interlink between MAFLD and polycystic ovary syndrome; pregnancy and MAFLD; MAFLD and gut microbiota; and more.
Provides in-depth clinical reviews of metabolic associated fatty liver disease, offering actionable insights for clinical practice.
Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. xi 7. Foreword - p. xiii 8. Preface - p. xv 9. Pathobiology of Metabolic-Associated Fatty Liver Disease - p. 405 10. Metabolic-Associated Fatty Liver Disease in Childhood and Adolescence - p. 417 11. Lean Metabolic-Associated Fatty Liver Disease - p. 431 12. Lipid Disorders and Metabolic-Associated Fatty Liver Disease - p. 445 13. Cardiovascular Implications of Metabolic Dysfunction-Associated Fatty Liver Disease - p. 459 14. Metabolic-Associated Fatty Liver Disease and Diabetes: A Double Whammy - p. 469 15. Metabolic-Associated Fatty Liver Disease and the Gut Microbiota - p. 485 16. Metabolic-Associated Fatty Liver Disease and Sarcopenia - p. 497 17. A Bidirectional Association Between Obstructive Sleep Apnea and Metabolic-Associated Fatty Liver Disease - p. 509 18. Pregnancy and Metabolic-Associated Fatty Liver Disease - p. 521 19. The Interlink Between Metabolic-Associated Fatty Liver Disease and Polycystic Ovary Syndrome - p. 533 20. Management of Metabolic-Associated Fatty Liver Disease - p. 547
